DGAT1 and melanoma: To determine whether loss of DGAT1 would perturb lipid droplet formation in melanoma cells, we used a DGAT1 inhibitor and CRISPR/Cas9 to knock out DGAT1 in our zebrafish melanoma lipid droplet reporter41 (Fig. 5a and Supplementary Fig. 8a, b).